Survival-related indicators ALOX12B and SPRR1A are associated with DNA damage repair and tumor microenvironment status in HPV 16-negative head and neck squamous cell carcinoma patients

• Published in: BMC cancer Vol. 22; no. 1; pp. 1 - 714
• Main Authors: Li, Jing, Tang, Ling-Long, Ma, Jun
• Format: Journal Article
• Language: English
• Published: London BioMed Central Ltd 29.06.2022; BioMed Central; BMC
• Subjects: AKT protein; AKT1 protein; Algorithms; Bioinformatics; Cancer; Cancer therapies; Cancer-associated fibroblasts; Cell differentiation; Cell migration; Chemotherapy; Development and progression; DNA damage; DNA damage response; DNA repair; Down-regulation; Drug metabolism; Drug resistance; Drug screening; Eigenvalues; Ferroptosis; Fibroblasts; Gene expression; Genetic aspects; Genomes; Glutathione; Head & neck cancer; Head and neck cancer; Head and neck carcinoma; Head and neck squamous cell carcinoma; Health aspects; Helper cells; Human papilloma virus 16-negative; Human papillomavirus; Immunotherapy; Infections; Initiation factor eIF-4E; Leukocytes (neutrophilic); Lymphocytes T; Medical prognosis; Metastases; Nucleotide sequence; Oncology, Experimental; Papillomavirus infections; Patient outcomes; Patients; PD-L1 protein; Protein binding; Protein-serine/threonine kinase; Proteins; Radiation therapy; Squamous cell carcinoma; Survival analysis; Tumor microenvironment; Tumors; China
• ISSN: 1471-2407; 1471-2407
• DOI: 10.1186/s12885-022-09722-x

Objectives To investigate prognostic-related gene signature based on DNA damage repair and tumor microenvironment statue in human papillomavirus 16 negative (HPV16-) head and neck squamous cell carcinoma (HNSCC). Methods For the RNA-sequence matrix in HPV16- HNSCC in the Cancer Genome Atlas (TCGA) cohort, the DNA damage response (DDR) and tumor microenvironment (TM) status of each patient sample was estimated by using the ssGSEA algorithm. Through bioinformatics analysis in DDR_high/TM_high (n = 311) and DDR_high/TM_low (n = 53) groups, a survival-related gene signature was selected in the TCGA cohort. Two independent external validation cohorts (GSE65858 (n = 210) and GSE41613 (n = 97)) with HPV16- HNSCC patients validated the gene signature. Correlations among the clinical-related hub differentially expressed genes (DEGs) and infiltrated immunocytes were explored with the TIMER2.0 server. Drug screening based on hub DEGs was performed using the CellMiner and GSCALite databases. The loss-of-function studies were used to evaluate the effect of screened survival-related gene on the motility of HPV- HNSCC cells in vitro. Results A high DDR level (P = 0.025) and low TM score (P = 0.012) were independent risk factors for HPV16- HNSCC. Downregulated expression of ALOX12B or SPRR1A was associated with poor survival rate and advanced cancer stages. The pathway enrichment analysis showed the DDR_high/TM_low samples were enriched in glycosphingolipid biosynthesis-lacto and neolacto series, glutathione metabolism, platinum drug resistance, and ferroptosis pathways, while the DDR_high/TM_low samples were enriched in Th17 cell differentiation, Neutrophil extracellular trap formation, PD - L1 expression and PD - 1 checkpoint pathway in cancer. Notably, the expression of ALOX12B and SPRR1A were negatively correlated with cancer-associated fibroblasts (CAFs) infiltration and CAFs downstream effectors. Sensitivity to specific chemotherapy regimens can be derived from gene expressions. In addition, ALOX12B and SPRR1A expression was associated with the mRNA expression of insulin like growth factor 1 receptor (IGF1R), AKT serine/threonine kinase 1 (AKT1), mammalian target of rapamycin (MTOR), and eukaryotic translation initiation factor 4E binding protein 1 (EIF4EBP1) in HPV negative HNSCC. Down-regulation of ALOX12B promoted HPV- HNSCC cells migration and invasion in vitro. Conclusions ALOX12B and SPRR1A served as a gene signature for overall survival in HPV16- HNSCC patients, and correlated with the amount of infiltrated CAFs. The specific drug pattern was determined by the gene signature. Keywords: Cancer-associated fibroblasts, DNA damage response, Human papilloma virus 16-negative, Head and neck squamous cell carcinoma, Tumor microenvironment